Flexion Therapeutics is a specialty pharmaceutical company focused on the development and commercialization of novel, local therapies for the treatment of patients with musculoskeletal conditions, beginning with osteoarthritis (OA), a type of degenerative arthritis. The company is currently advancing a drug candidate that has the potential to provide rapid, powerful, and durable pain relief compared with existing therapies.

Our lead product candidate, Zilretta™ (also known as FX006) is a sustained-release, intra-articular, non-opioid investigational treatment in late-stage development for patients with moderate to severe OA pain.